Screener
Satellos Bioscience
MSLESatellos Bioscience is a medical - pharmaceuticals company in the healthcare sector trading on XNAS, led by CEO Francis Gleeson, with a market cap of $158.9M.
$158.91M-36.1%
We’re still putting together Satellos Bioscience’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.
Ask us to move Satellos Bioscience up the queue, and we’ll analyze its filings next.
Earnings
Next report
Date not yet announcedProfile
CountryCanada
Listed2021
Employees17.0
CEOFrancis Gleeson
SectorHealthcare
IndustryMedical - Pharmaceuticals
Websitesatellos.com
FilingsSEC EDGAR